Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future
Patrick Rossignol(Inserm), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Murray Epstein(University of Copenhagen), Faı̈ez Zannad(Centre d’Investigation Clinique Innovation Technologique de Nancy), W. Frank Peacock(Hennepin Healthcare Research Institute), Bertram Pitt(Bayer (Germany)), Matthieu Legrand(University of California, San Francisco), Mikhail Kosiborod(AstraZeneca (Brazil)), Steven M. Hollenberg(Cooper University Health Care), Étienne Gayat(Inserm), Csaba P. Kövesdy(University of Tennessee Health Science Center), Michael Emmett(Baylor University Medical Center), Mehmet Birhan Yılmaz(Istanbul University-Cerrahpaşa), Wendy Gattis Stough(Campbell University)
Cited by 126
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k